Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization

F. Crea, E. Giovannetti, P.L. Zinzani, R. Danesi

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	21-44
Journal	Critical Reviews in Oncology / Hematology
Volume	72
Issue number	1
DOIs	https://doi.org/10.1016/j.critrevonc.2008.10.014
Publication status	Published - 2009

Access to Document

@article{4be153e4ea17475f8a51b2dd41195c94,

title = "Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization",

author = "F. Crea and E. Giovannetti and P.L. Zinzani and R. Danesi",

year = "2009",

doi = "https://doi.org/10.1016/j.critrevonc.2008.10.014",

language = "Undefined/Unknown",

volume = "72",

pages = "21--44",

journal = "Critical Reviews in Oncology / Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization

AU - Crea, F.

AU - Giovannetti, E.

AU - Zinzani, P.L.

AU - Danesi, R.

PY - 2009

Y1 - 2009

U2 - https://doi.org/10.1016/j.critrevonc.2008.10.014

DO - https://doi.org/10.1016/j.critrevonc.2008.10.014

M3 - Article

C2 - 19111474

SN - 1040-8428

VL - 72

SP - 21

EP - 44

JO - Critical Reviews in Oncology / Hematology

JF - Critical Reviews in Oncology / Hematology

IS - 1

ER -